PHARMACIST LED DEPRESCRIBING AND FOLLOW-UP IN A SUBACUTE MULTIDISCIPLINARY OUTPATIENT CLINIC: A PILOT RANDOMISED CONTROLLED TRIAL
6ER-032
PUBLIC OPINION AND PERSONAL SITUATION IN TIMES OF THE COVID-19 PANDEMIC
6ER-031
DEVELOPMENT OF PATIENT CENTRED VIDEO ON MEDICATION MANAGEMENT AND A QUALITATIVE EXPLORATION OF PATIENTS' OPINIONS TOWARDS THE VIDEO
6ER-030
AN ANNUAL REVIEW OF DRUG SHORTAGES MANAGED BY THE MMUH PHARMACY DEPARTMENT
6ER-029
IMPACT OF MEDICINES INFORMATION APP ON MEDICATION KNOWLEDGE AND WORRY IN POST-MYOCARDIAL INFARCTION PATIENTS
6ER-028
BARICITINIB AGAINST SEVERE COVID-19: EFFECTIVENESS AND SAFETY IN HOSPITAL CARE
6ER-027
IMPROVEMENT IN SELF-MANAGEMENT OF BIOLOGICAL DMARDS FOR PATIENTS WITH CHRONIC INFLAMMATORY ARTHRITIS WHEN A PHARMACIST PARTICIPATES IN A MULTIDISCIPLINARY CONSULTATION
6ER-026
CREDIBILITY OF SUBGROUP CLAIMS IN HAEMATOLOGY CLINICAL TRIALS
6ER-025
IMPORTANCE OF APPROPRIATE BEFORE-AND-AFTER QUASI-EXPERIMENTAL DESIGN TO EVALUATE THE IMPACT OF ANTIMICROBIAL STEWARDSHIP PROGRAMMES: COMPARATIVE RESULTS USING STATISTICAL HYPOTHESIS TESTING OR INTERRUPTED TIME SERIES ANALYSIS
6ER-024
WHAT OUR PATIENTS KNOW ABOUT ANTIBIOTICS AND ANTIMICROBIAL RESISTANCE. ARE THEY AWARE OF HOW TO MAKE GOOD USE OF THEM?
6ER-023
THE ROLE OF INSTITUTIONAL REVIEW BOARDS, AND HOSPITAL PHARMACISTS AS MEMBERS, IN THE INFORMED CONSENT PROCESS IN CLINICAL RESEARCH: A RETROSPECTIVE OBSERVATIONAL STUDY (submitted in 2019)
6ER-022
PERCEPTION OF RARE DISEASES AND ORPHAN MEDICINES (submitted in 2019)
6ER-021
DEGREE OF BURNOUT AMONG PHARMACISTS IN ISRAEL (submitted in 2019)
6ER-020
STANDARDISATION OF PROCESSES BY ELECTRONIC ASSISTED PRESCRIPTION PROGRAMME IN A UNIVERSITY PAEDIATRIC HOSPITAL (submitted in 2019)
6ER-019
TEACHING AND LEARNING EFFECT ANALYSIS OF AN INTERPROFESSIONAL TRAINING PROGRAMME FOR UNDERGRADUATE PHARMACY INTERNS (submitted in 2019)
